Institutional investors purchased a net $107.6 thousand shares of SPNC during the quarter ended March 2016 and now own 106.11% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEEDER ASSET MANAGEMENT, INC. Bought 3.1 Thousand shares of Spectranetics Corp
BNP PARIBAS ARBITRAGE SNC Bought 651.00 shares of Spectranetics Corp
PRINCIPAL MANAGEMENT CORP. Bought 436.00 shares of Spectranetics Corp